The way people are accessing GLP-1 medications Semaglutide and Tirzepatide is going to become very limited after the drugs ...

Tirzepatide has been shown to help people lose more weight compared to semaglutide at the dosage regimens currently available ...

Eli Lilly ( NYSE: LLY) on Tuesday will file lawsuits against two companies that the drug giant is accusing of mass ...

Weight loss clinics, telehealth companies, physicians, and pharmacies that have been prescribing or dispensing compounded GLP ...

Results from the SUMMIT trial suggest that tirzepatide is as effective in preventing heart failure events in those with ...

There’s no question about the popularity of GLP-1 weight loss drugs like Ozempic and Wegovy, but some doctors are worried the ...

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

Among all antiobesity medications, the incremental cost-effectiveness ratios were $197,023 and $467,676 per quality-adjusted life-year for tirzepatide and semaglutide, respectively. HealthDay News ...

After the FDA declared shortages of the drugs over, for tirzepatide in December and semaglutide in February, it told pharmacies and companies they had a few months before they had to stop ...